Next Article in Journal
Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review
Next Article in Special Issue
The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies
Previous Article in Journal
Recruitment of Corticotropin-Releasing Hormone (CRH) Neurons in Categorically Distinct Stress Reactions in the Mouse Brain
Previous Article in Special Issue
Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia

Department of Microbiology, Faculty of Medicine, Kansai Medical University, Hirakata 573-1010, Osaka, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(14), 11737; https://doi.org/10.3390/ijms241411737
Submission received: 22 June 2023 / Revised: 18 July 2023 / Accepted: 20 July 2023 / Published: 21 July 2023
(This article belongs to the Special Issue Host and Human Oncovirus Interaction)

Abstract

Adult T cell leukemia (ATL) is an aggressive hematologic disease caused by human T cell leukemia virus type 1 (HTLV-1) infection. Various animal models of HTLV-1 infection/ATL have been established to elucidate the pathogenesis of ATL and develop appropriate treatments. For analyses employing murine models, transgenic and immunodeficient mice are used because of the low infectivity of HTLV-1 in mice. Each mouse model has different characteristics that must be considered before use for different HTLV-1 research purposes. HTLV-1 Tax and HBZ transgenic mice spontaneously develop tumors, and the roles of both Tax and HBZ in cell transformation and tumor growth have been established. Severely immunodeficient mice were able to be engrafted with ATL cell lines and have been used in preclinical studies of candidate molecules for the treatment of ATL. HTLV-1-infected humanized mice with an established human immune system are a suitable model to characterize cells in the early stages of HTLV-1 infection. This review outlines the characteristics of mouse models of HTLV-1 infection/ATL and describes progress made in elucidating the pathogenesis of ATL and developing related therapies using these mice.
Keywords: HTLV-1; ATL; Tax; HBZ; immunodeficient mouse; humanized mouse HTLV-1; ATL; Tax; HBZ; immunodeficient mouse; humanized mouse

Share and Cite

MDPI and ACS Style

Nakajima, S.; Okuma, K. Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia. Int. J. Mol. Sci. 2023, 24, 11737. https://doi.org/10.3390/ijms241411737

AMA Style

Nakajima S, Okuma K. Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia. International Journal of Molecular Sciences. 2023; 24(14):11737. https://doi.org/10.3390/ijms241411737

Chicago/Turabian Style

Nakajima, Shinsuke, and Kazu Okuma. 2023. "Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia" International Journal of Molecular Sciences 24, no. 14: 11737. https://doi.org/10.3390/ijms241411737

APA Style

Nakajima, S., & Okuma, K. (2023). Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia. International Journal of Molecular Sciences, 24(14), 11737. https://doi.org/10.3390/ijms241411737

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop